 Your new post is loading...
 Your new post is loading...
|
Scooped by
Ed Rybicki
March 29, 2016 11:29 AM
|
In March, the New York Blood Center pulled the funding for the chimp sanctuary where 66 of its retired research chimps live.
|
Scooped by
Ed Rybicki
March 29, 2016 11:27 AM
|
The humble phage known as M13 could hold the key to unraveling the misfolded proteins that underlie many diseases.
|
Scooped by
Ed Rybicki
March 29, 2016 8:10 AM
|
On 25 Mar 2016, the 1st batch of vaccine for HFMD caused by Enterovirus 71 -- Enterovirus 71 Inactivated Vaccine (or EV71 Inactivated Vaccine) -- was administered in Nanning. The significance is that EV71 Inactivated Vaccine has now formally begun usage in Guangxi. After commercialization, EV71 Inactivated Vaccine will 1st be used as a "Class II Vaccine" and administered on the basis of "Aware, Voluntary, Self-Pay," with each injection priced at 218 yuan [USD 33]. A spokesperson at Guangxi CDC said that Guangxi has purchased 30 000 doses of EV71 inactivated vaccine, which will gradually be allocated to 14 local disease control agencies. If parents wish to obtain the vaccine for their own children, they can go to local disease control agencies for detailed understanding of vaccination sites.
|
Scooped by
Ed Rybicki
March 29, 2016 3:46 AM
|
Tribeca Film Festival organizers reverse their decision to screen a documentary by discredited researcher Andrew Wakefield.
|
Scooped by
Ed Rybicki
March 29, 2016 2:56 AM
|
Bodies of 2 people who died recently in the city (Dar es Salaam) after suffering an illness likened to Ebola and dengue were yesterday [23 Mar 2016] interred by health officials under heightened precautions. The Citizen saw health workers wearing personal protective gear aboard a special vehicle carrying 2 caskets bearing the bodies of the deceased, headed for burial in the city. The bodies were being transported from the Muhimbili National Hospital (MNH) to Mwananyamala burial grounds in Konondoni District. This week, health authorities warned the public of diseases prevalent in Tanzania which resemble Ebola. The permanent secretary in the ministry of Health, Community Development, Gender, Children and the Elderly, Dr Mpoki Ulisubisya, mentioned the diseases to be dengue, yellow fever [or] Rift Valley fever (RVF). However, he stressed that other viral infections such as Ebola, Marburg and Zika fever have not been diagnosed in the country. The warning came after 2 people -- one from Iringa and another from Old Moshi -- fell ill and were rushed to MNH with symptoms of high fever and bleeding from body orifices. The reports come at a time when there is an outbreak of yellow fever in neighbouring Kenya. Two people died in Nairobi recently, and the Kenyan Ministry of Health issued an alert over the outbreak of the disease that has recently killed over 60 people in Angola, according to international media reports. The case of a person who died in Kenya was reported to have entered the country from Angola.
|
Scooped by
Ed Rybicki
March 24, 2016 4:22 AM
|
Sunless half-frozen oceans lurk deep beneath the surface
|
Scooped by
Ed Rybicki
March 24, 2016 3:38 AM
|
A widening scandal over illegal vaccine sales in China has sparked anger and drawn criticism from the government over glaring loopholes in the regulation of the world's second-largest medicine market.
|
Scooped by
Ed Rybicki
March 23, 2016 9:38 AM
|
A new isolate of the cabbage aphid virus Brevicoryne brassicae virus was identified from Brevicoryne brassicae aphids growing on wild mustard plants (Sinapis arvensis) in northern Israel. The virus genome was partially assembled from purified siRNA using the Illumina MiSeq Sequencing System with limited success. Combining classical viral RNA purification and RT-PCR amplification followed by traditional Sanger sequencing enabled obtaining the complete genomic sequence. The Israeli strain of BrBV shared 95 % nucleotide sequence identity with the BrBV found in the United Kingdom.
|
Scooped by
Ed Rybicki
March 23, 2016 7:41 AM
|
As for Ebola, the virus has been present in Central Africa since at least the mid-nineteen-seventies. It is known to proliferate in the bodies of wild bats, which come into contact with humans on the edge of the forest or around mango trees in yards. But early outbreaks did not affect large numbers of people; and for years, it seemed that major ones were unlikely. (Shah cites a microbiology paper from 2011 that referred to Ebola, in its title, as “a relatively minor public health threat for Africa.”) In 2014, however, the disease exploded in West Africa, killing thousands in Guinea, Sierra Leone, and Liberia. Why this happened still isn’t clear. At the time, Ebola probably was not new to that area. Research from the nineteen-eighties suggests that in one region of central Liberia, up to thirteen per cent of the population carried antibodies to Ebola in their blood and thus may have already been exposed to the virus. Once the outbreak began, however, the population densities of major cities helped to sustain its growth. So, too, did the limited capacity of hospitals in the area; the lack of basic protective gear, like gloves, among some health-care workers; and the slow response of the international community. “The most critical factor was time,” Rob Lever, a specialist registrar in infectious diseases at the Hospital for Tropical Diseases, in London, told me, noting that the World Health Organization took months to declare a public-health emergency.
|
Scooped by
Ed Rybicki
March 23, 2016 7:04 AM
|
The epidemiology of influenza swarms with incongruities, incongruities exhaustively detailed by the late British epidemiologist, Edgar Hope-Simpson. He was the first to propose a parsimonious theory explaining why influenza is, as Gregg said, "seemingly unmindful of traditional infectious disease behavioral patterns." Recent discoveries indicate vitamin D upregulates the endogenous antibiotics of innate immunity and suggest that the incongruities explored by Hope-Simpson may be secondary to the epidemiology of vitamin D deficiency. We identify – and attempt to explain – nine influenza conundrums: (1) Why is influenza both seasonal and ubiquitous and where is the virus between epidemics? (2) Why are the epidemics so explosive? (3) Why do they end so abruptly? (4) What explains the frequent coincidental timing of epidemics in countries of similar latitude? (5) Why is the serial interval obscure? (6) Why is the secondary attack rate so low? (7) Why did epidemics in previous ages spread so rapidly, despite the lack of modern transport? (8) Why does experimental inoculation of seronegative humans fail to cause illness in all the volunteers? (9) Why has influenza mortality of the aged not declined as their vaccination rates increased? We review recent discoveries about vitamin D's effects on innate immunity, human studies attempting sick-to-well transmission, naturalistic reports of human transmission, studies of serial interval, secondary attack rates, and relevant animal studies. We hypothesize that two factors explain the nine conundrums: vitamin D's seasonal and population effects on innate immunity, and the presence of a subpopulation of "good infectors." If true, our revision of Edgar Hope-Simpson's theory has profound implications for the prevention of influenza.
|
Scooped by
Ed Rybicki
March 23, 2016 3:31 AM
|
An experimental drug mixture can successfully fight the Ebola virus in monkeys, fully protecting them from lethal infections, according to a new study.
|
Scooped by
Ed Rybicki
March 23, 2016 3:15 AM
|
Much of the world already copes with the threat and reality of mosquito-borne viruses whose typical symptoms blow Zika’s out of the water.
|
Scooped by
Ed Rybicki
March 23, 2016 3:11 AM
|
A new therapy, harnessing the power of human antibodies, has eliminated an HIV-like virus from the bodies of two monkeys, in just two weeks, scientists have revealed. Monkeys are not susceptible to HIV, so researchers had to create a virus that was part HIV, part simian immunodeficiency virus - the HIV equivalent that infects monkeys. The infant rhesus macaques were given the treatment within 24 hours of being exposed to SHIV - the hybrid virus, that bears the HIV envelope protein. Tests performed two weeks later revealed they were completely cleared of the virus, scientists at the Oregon National Primate Research Center said. They hailed their findings a 'significant development' in the HIV scientific community, raising hopes of a new treatment which could save thousands of lives.
|
|
Scooped by
Ed Rybicki
March 29, 2016 11:27 AM
|
Why does ‘harm reduction’ continue to be such a problem for global drug policy when it’s a proven way of reducing cases of HIV?
|
Scooped by
Ed Rybicki
March 29, 2016 8:12 AM
|
There has been a squirrel pox virus outbreak among red squirrels at Tollymore Forest Park in County Down. The Department of the Environment (DoE) said it had been 5 years since the 1st recorded death due to the virus in Northern Ireland [see ProMED ref. below]. The Northern Ireland Environment Agency (NIEA) said there appeared to be "little natural resistance to the virus within the local population." NIEA Wildlife Inspector Declan Looney said red squirrels in Tollymore Forest had "recovered well" following the outbreak of the virus 5 years ago, but this was a "further blow." "Sick red squirrels will appear lethargic, approachable, with painful sores on their faces and paws," he said. "Unfortunately, there appears to be little natural resistance to the virus within the local population, and sick animals tend to die within 10 days to 2 weeks. If you have squirrels entering your garden to feed at bird feeders, please either remove or clean them daily to reduce the spread of the virus." The DoE said the disease "does not affect people or their domestic pets."
|
Scooped by
Ed Rybicki
March 29, 2016 5:05 AM
|
Genomics entrepreneur Craig Venter has created a synthetic cell that contains the smallest genome of any known, independent organism. Functioning with 473 genes, the cell is a milestone in his team’s 20-year quest to reduce life to its bare essentials and, by extension, to design life from scratch. Venter, who has co-founded a company that seeks to harness synthetic cells for making industrial products, says that the feat heralds the creation of customized cells to make drugs, fuels and other products. But an explosion in powerful ‘gene-editing’ techniques, which enable relatively easy and selective tinkering with genomes, raises a niggling question: why go to the trouble of making new life when you can simply tweak what already exists? Thomas Deerinck and Mark Ellisman/NCMIR/UCSD Each cell of JCVI-syn3.0 contains just 473 genes, fewer than any other independent organism. Unlike the first synthetic cells made in 20101, in which Venter’s team at the J. Craig Venter Institute in La Jolla, California, copied an existing bacterial genome and transplanted it into another cell, the genome of the minimal cells is like nothing in nature. Venter says that the cell, which is described in a paper released on 24 March in Science2, constitutes a brand new, artificial species.
|
Scooped by
Ed Rybicki
March 29, 2016 3:28 AM
|
If your country does not have year-round or seasonal dengue, this alert is NOT for you. But if it does, please take this alert seriously. There is a big epidemic of yellow fever (YF) going on in Angola, West Africa, with over 1000 cases and hundreds of deaths. Cases have spread to the Democratic Republic of the Congo, Kenya and Mauritania in Africa and to China, the 1st ever confirmed cases and deaths from YF in Asia. There is no YF epidemic in any of those other 3 African countries, yet. But it is the dengue season in them now and soon will be in southern China. Since YF is spread by _Aedes aegypti_, one of the mosquitoes that spread dengue (and chikungunya and Zika viruses), there is an obvious risk. Look at how fast chikungunya and Zika have spread across the world. But those do not kill many people (apart from perinatal birth defects in the case of Zika). However, in the case of YF, 20 percent of unvaccinated people die. Of course, we have a vaccine, but world stocks of 7 million doses have been exhausted just to protect the population of Luanda, Angola's capital. 18 million more are needed for the rest of the country, but only half that number will be available by the end of next month (April 2016); 19 million are on contracts to UNICEF and could be repurposed. Around 40 million more may be available by the end of the year [2016], but China will need 300 million if it spreads across its dengue-endemic provinces. If YF were to spread in Asia, where 2 billion are at risk in 18 dengue-affected countries, hundreds of thousands could die before YF vaccine stocks could be boosted and delivered. Apocalyptic forecasts of the numbers of fatalities from Ebola turned out to be wildly wrong, and we can hope that will again be the case here, but given the way Zika has exploded in the Western hemisphere, we can`t count on it.
|
Scooped by
Ed Rybicki
March 24, 2016 4:24 AM
|
Latest WHO influenza update
|
Scooped by
Ed Rybicki
March 24, 2016 4:17 AM
|
A journal article says herpes virus and Lyme disease bacteria are behind the mind-robbing illness, but not all researchers are convinced
|
Scooped by
Ed Rybicki
March 24, 2016 3:30 AM
|
NASA's Dawn spacecraft zoomed in on dwarf planet Ceres and found unexpected treasures hidden in its craters
|
Scooped by
Ed Rybicki
March 23, 2016 8:46 AM
|
The Beijing Municipal Commission of Health and Family Planning on Monday announced one more imported yellow fever case, making a total of four in the capital. The patient, a 50-year-old man from southeast China's Fujian Province, began running a fever in Angola on March 6, and had sought treatment in several local hospitals. He had not been vaccinated before going to Angola and informed Beijing Entry-Exit Inspection and Quarantine Bureau of his arrival on March 18. He tested positive for yellow fever at Beijing Capital International Airport and was sent to hospital. His condition was described as "serious." Beijing had reported three imported yellow fever cases since March 13, all returnees from Angola.
|
Scooped by
Ed Rybicki
March 23, 2016 7:37 AM
|
Guinea's Ebola coordination unit has traced an estimated 816 people who may have come into contact with victims of the disease or their corpses during a recent flare-up in a village in the country's southeast, a health official said on Monday.
|
Scooped by
Ed Rybicki
March 23, 2016 7:02 AM
|
According to recent statistics, 96 million apparent dengue infections were estimated worldwide in 2010. This figure is by far greater than the WHO prediction which indicates the rapid spread of this disease posing a growing threat to the economy and a major challenge to clinicians and health care services across the globe particularly in the affected areas. This article aims at bringing to light the current epidemiological and clinical status of the dengue fever. The relationship between genetic mutations, single nucleotide polymorphism (SNP) and the pathophysiology of disease progression will be put into perspective. It will also highlight the recent advances in dengue vaccine development. Thus far, a significant progress has been made in unraveling the risk factors and understanding the molecular pathogenesis associated with the disease. However, further insights in molecular features of the disease and the development of animal models will enormously help improving the therapeutic interventions and potentially contribute to finding new preventive measures for population at risk.
|
Scooped by
Ed Rybicki
March 23, 2016 3:20 AM
|
Inovio Pharmaceuticals, Inc. (INO) announced today that its novel dMAb antibody and DNA vaccine targeting the chikungunya virus (CHIKV) provided 100% protection against a lethal virus challenge in mice. This breakthrough data was published in the latest issue of The Journal of Infectious Diseases in a paper, “Rapid and long-term immunity elicited by DNA encoded antibody prophylaxis and DNA vaccination against Chikungunya virus,” prepared by Inovio authors and their academic collaborators. While conventional vaccine and marketed monoclonal antibody technologies have shown limited ability to provide an effective solution to CHIKV to date, Inovio’s DNA vaccine and dMAb products show potential, separately and in combination, to offer immediate and long term protection to large populations from CHIKV infection.
|
Scooped by
Ed Rybicki
March 23, 2016 3:13 AM
|
A new technology developed by biochemists from the University of Manchester in the United Kingdom is touted to contain the flu. In partnership with biotech firm Virustatic, the researchers produced a fabric coating that isolates viruses responsible for seasonal and pandemic flu. The so-called germ trap — which can be incorporated in filters of masks or air filtration systems — is said to have a virus capture rate of more than 99 percent.
|